International Cospas-Sarsat Programme – Trademark Portfolio
Entity Type: 99
International Cospas-Sarsat Programme holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 45 (Legal & Security Services) — 5 filings in this category. Currently, 4 trademarks are registered. Notable registered marks include COSPAS SARSAT, COSPAS-SARSAT, and INTERNATIONAL SATELLITE SYSTEM COSPAS SARSAT SEARCH AND RESCUE. The owner is based in Montreal, Quebec.
700 de la Gauchetière West, Suite 2450
Montreal, Quebec H3B5M2 , CA
Showing of trademarks Trademarks
Trademark Classifications
International Cospas-Sarsat Programme's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does International Cospas-Sarsat Programme have?
International Cospas-Sarsat Programme has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned.
What trademark classes does International Cospas-Sarsat Programme file in?
International Cospas-Sarsat Programme files trademarks across 1 Nice Classification class. The most active classes are Class 45 (Legal & Security Services). Class 45 covers legal services; security services for the protection of property and individuals.
What are International Cospas-Sarsat Programme's most well-known trademarks?
International Cospas-Sarsat Programme's registered trademark portfolio includes well-known marks such as COSPAS SARSAT, COSPAS-SARSAT, and INTERNATIONAL SATELLITE SYSTEM COSPAS SARSAT SEARCH AND RESCUE. These are among 4 currently registered trademarks in the portfolio.
What is International Cospas-Sarsat Programme's trademark registration success rate?
International Cospas-Sarsat Programme has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.